Generation and Characterization of Human Cytokine-Producing B Cell Effectors

产生人类细胞因子的 B 细胞效应子的生成和表征

基本信息

  • 批准号:
    7963622
  • 负责人:
  • 金额:
    $ 22.98万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2010
  • 资助国家:
    美国
  • 起止时间:
    2010-05-15 至 2012-04-30
  • 项目状态:
    已结题

项目摘要

Project Summary B cells are important for the generation of protective immunity and function at multiple discrete stages. The unique role that B cells play as antibody-producing cells is appreciated, however the other functions of B cells as antigen presenting cells, lymphoid tissue organizers and cytokine-producing effector or regulatory cells are much less understood and rarely studied. Recent work from our lab showed that cytokine producing effector B cells play crucial roles in the development of protective humoral and cellular immunity to infectious agents. We therefore hypothesized that there are specialized populations of B cells that have the ability to secrete cytokines and regulate immune responses. To address this hypothesis, we developed an in vitro culture system using primary mouse B cell to generate different classes of cytokine producing effector B cells. We characterized these in vitro generated cells and found markers that we subsequently used to identify the cytokine producing B cell subpopulations in vivo. For example, using markers identified in our in vitro cultures, we can now identify IFNγ producing B cell effectors in vivo and showed that these B cells are specifically induced in response to influenza infection and are elevated in number in some mouse models of autoimmunity. Thus, this approach has allowed us for the first time to visualize B cell effectors in vivo and has opened the door to functional and mechanistic studies that will reveal the roles for these cells in infectious and autoimmune disease. Despite the significant progress that we have made in our studies of mouse effector B cells, little is known about their human B cell counterparts. In fact, only very rudimentary studies have been conducted to date with human B cells. From these limited studies it is clear that human B cells have the potential to make cytokines under some stimulation conditions. However, these studies have been conducted with bulk peripheral blood B cells, thus the effector human B cells subsets remain to be identified. The goals of this proposal are to (i) to develop an in vitro culture system to phenotypically and functionally characterize human effector B cells and (ii) To use the information that we have obtained from the in vitro cultures to identify effector B cells in samples from healthy and autoimmune individuals.
项目摘要 B细胞对于保护性免疫的产生和在多个离散阶段的功能是重要的。这个 B细胞作为抗体产生细胞的独特作用受到重视,但B细胞的其他功能 作为抗原提呈细胞、淋巴组织组织者和细胞因子产生的效应者或调节细胞 更少人了解,也很少研究。我们实验室最近的研究表明,产生细胞因子的效应器B 细胞在发展对感染性病原体的保护性体液和细胞免疫中起着至关重要的作用。我们 因此假设存在特殊的B细胞群体,它们具有分泌 细胞因子和调节免疫反应。为了解决这一假设,我们开发了一种体外培养 该系统利用原代小鼠B细胞产生不同类别的细胞因子,产生效应性B细胞。我们 对这些体外产生的细胞进行了表征,并找到了我们随后用来识别 体内产生B细胞亚群的细胞因子。例如,使用我们的体外培养中识别的标记, 我们现在可以在体内识别产生干扰素的B细胞效应器,并表明这些B细胞是特异的 在对流感感染的反应中诱导,并在某些自身免疫的小鼠模型中数量增加。 因此,这种方法使我们第一次能够在体内可视化B细胞效应器,并打开了 进行功能和机制研究,揭示这些细胞在感染和自身免疫中的作用 疾病。尽管我们在小鼠效应B细胞的研究中取得了重大进展,但几乎没有 已经知道了他们的人类B细胞对应物。事实上,只进行了非常初级的研究,以 与人类B细胞约会。从这些有限的研究中可以清楚地看出,人类B细胞有可能使 某些刺激条件下的细胞因子。然而,这些研究都是批量进行的。 外周血液中的B细胞,因此人类B细胞亚群的效应者仍有待鉴定。这样做的目的是 建议是(I)开发一种体外培养系统,以表型和功能表征人类 效应B细胞和(Ii)使用我们从体外培养中获得的信息来鉴定 健康人和自身免疫者样本中的效应器B细胞。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Frances E. Lund其他文献

Transcription factor T-bet regulates the maintenance and differentiation potential of lymph node and lung effector memory B cell subsets
转录因子 T 细胞结合抑制因子调节淋巴结和肺效应记忆 B 细胞亚群的维持和分化潜能
  • DOI:
    10.1016/j.immuni.2025.05.021
  • 发表时间:
    2025-07-08
  • 期刊:
  • 影响因子:
    26.300
  • 作者:
    Christopher A. Risley;Michael D. Schultz;S. Rameeza Allie;Shanrun Liu;Jessica N. Peel;Anoma Nellore;Christopher F. Fucile;Christopher D. Scharer;Jeremy M. Boss;Troy D. Randall;Alexander F. Rosenberg;Frances E. Lund
  • 通讯作者:
    Frances E. Lund
IgM Memory Cells: First Responders in Malaria
  • DOI:
    10.1016/j.immuni.2016.08.005
  • 发表时间:
    2016-08-16
  • 期刊:
  • 影响因子:
  • 作者:
    Sara L. Stone;Frances E. Lund
  • 通讯作者:
    Frances E. Lund
This information is current as Infection in Mice Pneumocystis Clearance of T Cells for + Early Priming of CD 4 B Lymphocytes Are Required during the Feola
此信息是最新的,因为小鼠肺孢子虫感染在 Feola 期间需要清除 T 细胞以早期启动 CD 4 B 淋巴细胞
  • DOI:
  • 发表时间:
    2015
  • 期刊:
  • 影响因子:
    0
  • 作者:
    M. Opata;M. Hollifield;Frances E. Lund;Troy D. Randall;Robert Dunn;B. Garvy;D. Feola
  • 通讯作者:
    D. Feola
Signaling through CD38 augments B cell antigen receptor (BCR) responses and is dependent on BCR expression.
通过 CD38 的信号传导可增强 B 细胞抗原受体 (BCR) 反应,并且依赖于 BCR 表达。
  • DOI:
    10.4049/jimmunol.157.4.1455
  • 发表时间:
    1996
  • 期刊:
  • 影响因子:
    4.4
  • 作者:
    Frances E. Lund;N.;K. M. Kim;M. Reth;Maureen Howard
  • 通讯作者:
    Maureen Howard
This information is current as MechanismsStrains of Influenza via Multiple B Cells Promote Resistance to Heterosubtypic and
该信息是最新的,因为机制流感菌株通过多个 B 细胞促进对异亚型和
  • DOI:
  • 发表时间:
    2007
  • 期刊:
  • 影响因子:
    0
  • 作者:
    J. Rangel;D. Carragher;Ravi S. Misra;Kim L. Kusser;Louise Hartson;A. Moquin;Frances E. Lund;T. Randall
  • 通讯作者:
    T. Randall

Frances E. Lund的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Frances E. Lund', 18)}}的其他基金

TLR7 and TLR9-directed plasma cell formation: Dissecting the molecular basis for their differential dependence on IFN-induced signals
TLR7 和 TLR9 定向浆细胞形成:剖析它们对 IFN 诱导信号的差异依赖性的分子基础
  • 批准号:
    10642784
  • 财政年份:
    2020
  • 资助金额:
    $ 22.98万
  • 项目类别:
TLR7 and TLR9-directed plasma cell formation: Dissecting the molecular basis for their differential dependence on IFN-induced signals
TLR7 和 TLR9 定向浆细胞形成:剖析它们对 IFN 诱导信号的差异依赖性的分子基础
  • 批准号:
    10431929
  • 财政年份:
    2020
  • 资助金额:
    $ 22.98万
  • 项目类别:
Tissue and organ specific human B cell immunity
组织和器官特异性人类 B 细胞免疫
  • 批准号:
    10265689
  • 财政年份:
    2020
  • 资助金额:
    $ 22.98万
  • 项目类别:
TLR7 and TLR9-directed plasma cell formation: Dissecting the molecular basis for their differential dependence on IFN-induced signals
TLR7 和 TLR9 定向浆细胞形成:剖析它们对 IFN 诱导信号的差异依赖性的分子基础
  • 批准号:
    10032785
  • 财政年份:
    2020
  • 资助金额:
    $ 22.98万
  • 项目类别:
Identification and characterization of effector memory B cell populations that dominate memory responses to subsequent influenza infection and vaccination
效应记忆 B 细胞群的鉴定和表征,该细胞群主导对随后流感感染和疫苗接种的记忆反应
  • 批准号:
    10227903
  • 财政年份:
    2020
  • 资助金额:
    $ 22.98万
  • 项目类别:
Identification and characterization of effector memory B cell populations that dominate memory responses to subsequent influenza infection and vaccination
效应记忆 B 细胞群的鉴定和表征,该细胞群主导对随后流感感染和疫苗接种的记忆反应
  • 批准号:
    10455632
  • 财政年份:
    2020
  • 资助金额:
    $ 22.98万
  • 项目类别:
TLR7 and TLR9-directed plasma cell formation: Dissecting the molecular basis for their differential dependence on IFN-induced signals
TLR7 和 TLR9 定向浆细胞形成:剖析它们对 IFN 诱导信号的差异依赖性的分子基础
  • 批准号:
    10214491
  • 财政年份:
    2020
  • 资助金额:
    $ 22.98万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10395996
  • 财政年份:
    2019
  • 资助金额:
    $ 22.98万
  • 项目类别:
Characterization of virus-specific human B cell subsets in lymphoid and non-lymphoid tissues
淋巴和非淋巴组织中病毒特异性人类 B 细胞亚群的表征
  • 批准号:
    10592418
  • 财政年份:
    2019
  • 资助金额:
    $ 22.98万
  • 项目类别:
Tissue and organ specific human B cell immunity
组织和器官特异性人类 B 细胞免疫
  • 批准号:
    10592408
  • 财政年份:
    2019
  • 资助金额:
    $ 22.98万
  • 项目类别:

相似海外基金

University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
  • 批准号:
    10073243
  • 财政年份:
    2024
  • 资助金额:
    $ 22.98万
  • 项目类别:
    Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
  • 批准号:
    10752129
  • 财政年份:
    2024
  • 资助金额:
    $ 22.98万
  • 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
  • 批准号:
    2339201
  • 财政年份:
    2024
  • 资助金额:
    $ 22.98万
  • 项目类别:
    Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
  • 批准号:
    MR/Y008693/1
  • 财政年份:
    2024
  • 资助金额:
    $ 22.98万
  • 项目类别:
    Research Grant
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
  • 批准号:
    23K14783
  • 财政年份:
    2023
  • 资助金额:
    $ 22.98万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
  • 批准号:
    23KJ0394
  • 财政年份:
    2023
  • 资助金额:
    $ 22.98万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
  • 批准号:
    10076445
  • 财政年份:
    2023
  • 资助金额:
    $ 22.98万
  • 项目类别:
    Grant for R&D
PLA2G2D Antibodies for Cancer Immunotherapy
用于癌症免疫治疗的 PLA2G2D 抗体
  • 批准号:
    10699504
  • 财政年份:
    2023
  • 资助金额:
    $ 22.98万
  • 项目类别:
Genetic adjuvants to elicit neutralizing antibodies against HIV
基因佐剂可引发抗艾滋病毒中和抗体
  • 批准号:
    10491642
  • 财政年份:
    2023
  • 资助金额:
    $ 22.98万
  • 项目类别:
Novel Immunogens to Elicit Broadly Cross-reactive Antibodies That Target the Hemagglutinin Head Trimer Interface
新型免疫原可引发针对血凝素头三聚体界面的广泛交叉反应抗体
  • 批准号:
    10782567
  • 财政年份:
    2023
  • 资助金额:
    $ 22.98万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了